We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RFIL icon
4001
RF Industries
RFIL
$134M
$441K ﹤0.01%
59,204
+11,436
+24% +$80.8K
MYPS icon
4002
PLAYSTUDIOS Inc
MYPS
$77.9M
$440K ﹤0.01%
+59,380
New +$574K
GIFI
4003
DELISTED
Gulf Island Fabrication
GIFI
$439K ﹤0.01%
97,136
+2,818
+3% +$12.7K
NVNO
4004
enVVeno Medical
NVNO
$7.08M
$437K ﹤0.01%
1,822
+786
+76% +$169K
CYTH
4005
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$435K ﹤0.01%
42,577
+24,320
+133% +$204K
BPTH
4006
DELISTED
Bio-Path Holdings Inc
BPTH
$435K ﹤0.01%
3,268
+438
+15% +$54K
AGFS
4007
DELISTED
AgroFresh Solutions Inc
AGFS
$435K ﹤0.01%
209,193
-199,214
-49% -$429K
DVLT
4008
Datavault AI
DVLT
$291M
$434K ﹤0.01%
7
VBFC
4009
DELISTED
Village Bank and Trust Financial Corp.
VBFC
$434K ﹤0.01%
8,883
JKS
4010
JinkoSolar
JKS
$793M
$433K ﹤0.01%
7,731
ALF
4011
DELISTED
ALFI Inc
ALF
$432K ﹤0.01%
+29,404
New +$173K
MRUS
4012
DELISTED
Merus
MRUS
$431K ﹤0.01%
20,484
+5,452
+36% +$121K
SVFA
4013
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$429K ﹤0.01%
43,423
+12,241
+39% +$123K
CEMI
4014
DELISTED
Chembio diagnostics, Inc.
CEMI
$429K ﹤0.01%
144,622
-156,124
-52% -$544K
NWG icon
4015
NatWest
NWG
$75.4B
$428K ﹤0.01%
70,511
+2,624
+4% +$15.9K
SPRT
4016
DELISTED
support.com, Inc.
SPRT
$427K ﹤0.01%
110,863
-38,289
-26% -$139K
CGRN
4017
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$425K ﹤0.01%
75,742
+13,600
+22% +$103K
LUXA
4018
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
$424K ﹤0.01%
+42,873
New +$431K
KARO icon
4019
Karooooo
KARO
$1.98B
$423K ﹤0.01%
+11,529
New +$420K
ALLT icon
4020
Allot
ALLT
$372M
$421K ﹤0.01%
21,262
GNCA
4021
DELISTED
Genocea Biosciences, Inc.
GNCA
$420K ﹤0.01%
179,714
+6,307
+4% +$15.2K
AEHR icon
4022
Aehr Test Systems
AEHR
$2.61B
$419K ﹤0.01%
151,947
+4,049
+3% +$9.69K
MAG
4023
DELISTED
MAG Silver
MAG
$419K ﹤0.01%
20,062
SNRH
4024
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
$418K ﹤0.01%
42,992
+22,159
+106% +$217K
IJR icon
4025
iShares Core S&P Small-Cap ETF
IJR
$109B
0

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.